世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

経皮鎮痛薬-世界市場シェアとランキング、全体売上高と需要予測 2025-2031

経皮鎮痛薬-世界市場シェアとランキング、全体売上高と需要予測 2025-2031


Transdermal Analgesics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

経皮鎮痛薬の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。 経皮吸収型鎮痛薬の北米市場は、2... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年3月21日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

経皮鎮痛薬の世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。

経皮吸収型鎮痛薬の北米市場は、2024年に100万米ドル規模となり、2025年から2031年の予測期間中に年平均成長率%で、2031年には100万米ドルに達すると予測されています。
経皮鎮痛薬のアジア太平洋市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に%のCAGRで、2031年までに100万ドルに達するだろう。
経皮鎮痛薬のヨーロッパ市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に%のCAGRで、2031年までに100万ドルに達するでしょう。

経皮鎮痛薬の世界的な主要企業には、アボット・ラボラトリーズ、アッヴィ社、バイエル社、イーライリリー・アンド・カンパニー、エンド・ファーマシューティカルズ、グラクソスミスクライン社、ジョンソン・アンド・ジョンソンmd&d社、ファイザー社、レキットベンキーザー・グループ、サノフィ社などがあります。2024年には、世界の大手5社が売上高で約 %のシェアを占めています。
本レポートは、経皮吸収型鎮痛薬の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別の経皮吸収型鎮痛薬の分析とともに、総販売量、販売収益、価格、主要企業の市場シェアとランキングに焦点を当てています。

経皮吸収型鎮痛薬の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売数量(K単位)と販売収益(百万ドル)で提供されます。量的および質的分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、経皮鎮痛薬に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。

市場区分
企業別
アボット・ラボラトリーズ
アッヴィ社
バイエル
イーライリリー・アンド・カンパニー
グラクソスミスクライン plc
ジョンソン・アンド・ジョンソン MD&D
ファイザー
レキットベンキーザーグループ
サノフィ
タイプ別セグメント
非オピオイド
オピオイド
用途別セグメント
病院
薬局
ファミリー
地域別
北米
アメリカ
カナダ
アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア太平洋地域
ヨーロッパ
ドイツ
フランス
英国
イタリア
オランダ
北欧諸国
その他のヨーロッパ
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートの対象範囲、世界の総市場規模(金額、数量、価格)を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。
第2章:経皮吸収型鎮痛薬メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。
第3章:タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのを助ける。
第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。
第5章:経皮鎮痛薬の地域別売上高、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介しています。
第6章:経皮吸収型鎮痛薬の国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。
第7章:主要企業のプロファイルを提供し、製品の売上高、収益、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:結論


ページTOPに戻る


目次

1 Market Overview
1.1 Transdermal Analgesics Product Introduction
1.2 Global Transdermal Analgesics Market Size Forecast
1.2.1 Global Transdermal Analgesics Sales Value (2020-2031)
1.2.2 Global Transdermal Analgesics Sales Volume (2020-2031)
1.2.3 Global Transdermal Analgesics Sales Price (2020-2031)
1.3 Transdermal Analgesics Market Trends & Drivers
1.3.1 Transdermal Analgesics Industry Trends
1.3.2 Transdermal Analgesics Market Drivers & Opportunity
1.3.3 Transdermal Analgesics Market Challenges
1.3.4 Transdermal Analgesics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transdermal Analgesics Players Revenue Ranking (2024)
2.2 Global Transdermal Analgesics Revenue by Company (2020-2025)
2.3 Global Transdermal Analgesics Players Sales Volume Ranking (2024)
2.4 Global Transdermal Analgesics Sales Volume by Company Players (2020-2025)
2.5 Global Transdermal Analgesics Average Price by Company (2020-2025)
2.6 Key Manufacturers Transdermal Analgesics Manufacturing Base and Headquarters
2.7 Key Manufacturers Transdermal Analgesics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Analgesics
2.9 Transdermal Analgesics Market Competitive Analysis
2.9.1 Transdermal Analgesics Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Analgesics Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Analgesics as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Non opioids
3.1.2 Opioids
3.2 Global Transdermal Analgesics Sales Value by Type
3.2.1 Global Transdermal Analgesics Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Transdermal Analgesics Sales Value, by Type (2020-2031)
3.2.3 Global Transdermal Analgesics Sales Value, by Type (%) (2020-2031)
3.3 Global Transdermal Analgesics Sales Volume by Type
3.3.1 Global Transdermal Analgesics Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Transdermal Analgesics Sales Volume, by Type (2020-2031)
3.3.3 Global Transdermal Analgesics Sales Volume, by Type (%) (2020-2031)
3.4 Global Transdermal Analgesics Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Family
4.2 Global Transdermal Analgesics Sales Value by Application
4.2.1 Global Transdermal Analgesics Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Transdermal Analgesics Sales Value, by Application (2020-2031)
4.2.3 Global Transdermal Analgesics Sales Value, by Application (%) (2020-2031)
4.3 Global Transdermal Analgesics Sales Volume by Application
4.3.1 Global Transdermal Analgesics Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Transdermal Analgesics Sales Volume, by Application (2020-2031)
4.3.3 Global Transdermal Analgesics Sales Volume, by Application (%) (2020-2031)
4.4 Global Transdermal Analgesics Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Transdermal Analgesics Sales Value by Region
5.1.1 Global Transdermal Analgesics Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Transdermal Analgesics Sales Value by Region (2020-2025)
5.1.3 Global Transdermal Analgesics Sales Value by Region (2026-2031)
5.1.4 Global Transdermal Analgesics Sales Value by Region (%), (2020-2031)
5.2 Global Transdermal Analgesics Sales Volume by Region
5.2.1 Global Transdermal Analgesics Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Transdermal Analgesics Sales Volume by Region (2020-2025)
5.2.3 Global Transdermal Analgesics Sales Volume by Region (2026-2031)
5.2.4 Global Transdermal Analgesics Sales Volume by Region (%), (2020-2031)
5.3 Global Transdermal Analgesics Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Transdermal Analgesics Sales Value, 2020-2031
5.4.2 North America Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Transdermal Analgesics Sales Value, 2020-2031
5.5.2 Europe Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Transdermal Analgesics Sales Value, 2020-2031
5.6.2 Asia Pacific Transdermal Analgesics Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Transdermal Analgesics Sales Value, 2020-2031
5.7.2 South America Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Transdermal Analgesics Sales Value, 2020-2031
5.8.2 Middle East & Africa Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transdermal Analgesics Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Transdermal Analgesics Sales Value
6.2.1 Key Countries/Regions Transdermal Analgesics Sales Value, 2020-2031
6.2.2 Key Countries/Regions Transdermal Analgesics Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Transdermal Analgesics Sales Value, 2020-2031
6.3.2 United States Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Transdermal Analgesics Sales Value, 2020-2031
6.4.2 Europe Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Transdermal Analgesics Sales Value, 2020-2031
6.5.2 China Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.5.3 China Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Transdermal Analgesics Sales Value, 2020-2031
6.6.2 Japan Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Transdermal Analgesics Sales Value, 2020-2031
6.7.2 South Korea Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Transdermal Analgesics Sales Value, 2020-2031
6.8.2 Southeast Asia Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Transdermal Analgesics Sales Value, 2020-2031
6.9.2 India Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.9.3 India Transdermal Analgesics Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Information
7.1.2 Abbott Laboratories Introduction and Business Overview
7.1.3 Abbott Laboratories Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abbott Laboratories Transdermal Analgesics Product Offerings
7.1.5 Abbott Laboratories Recent Development
7.2 AbbVie Inc.
7.2.1 AbbVie Inc. Company Information
7.2.2 AbbVie Inc. Introduction and Business Overview
7.2.3 AbbVie Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 AbbVie Inc. Transdermal Analgesics Product Offerings
7.2.5 AbbVie Inc. Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Company Information
7.3.2 Bayer AG Introduction and Business Overview
7.3.3 Bayer AG Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bayer AG Transdermal Analgesics Product Offerings
7.3.5 Bayer AG Recent Development
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Information
7.4.2 Eli Lilly and Company Introduction and Business Overview
7.4.3 Eli Lilly and Company Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Eli Lilly and Company Transdermal Analgesics Product Offerings
7.4.5 Eli Lilly and Company Recent Development
7.5 endo pharmaceuticals, Glaxosmithkline plc
7.5.1 endo pharmaceuticals, Glaxosmithkline plc Company Information
7.5.2 endo pharmaceuticals, Glaxosmithkline plc Introduction and Business Overview
7.5.3 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Product Offerings
7.5.5 endo pharmaceuticals, Glaxosmithkline plc Recent Development
7.6 johnson and johnson md&d
7.6.1 johnson and johnson md&d Company Information
7.6.2 johnson and johnson md&d Introduction and Business Overview
7.6.3 johnson and johnson md&d Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 johnson and johnson md&d Transdermal Analgesics Product Offerings
7.6.5 johnson and johnson md&d Recent Development
7.7 Pfizer, Inc.
7.7.1 Pfizer, Inc. Company Information
7.7.2 Pfizer, Inc. Introduction and Business Overview
7.7.3 Pfizer, Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Pfizer, Inc. Transdermal Analgesics Product Offerings
7.7.5 Pfizer, Inc. Recent Development
7.8 Reckitt Benckiser Group
7.8.1 Reckitt Benckiser Group Company Information
7.8.2 Reckitt Benckiser Group Introduction and Business Overview
7.8.3 Reckitt Benckiser Group Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Reckitt Benckiser Group Transdermal Analgesics Product Offerings
7.8.5 Reckitt Benckiser Group Recent Development
7.9 Sanofi
7.9.1 Sanofi Company Information
7.9.2 Sanofi Introduction and Business Overview
7.9.3 Sanofi Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Sanofi Transdermal Analgesics Product Offerings
7.9.5 Sanofi Recent Development
8 Industry Chain Analysis
8.1 Transdermal Analgesics Industrial Chain
8.2 Transdermal Analgesics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transdermal Analgesics Sales Model
8.5.2 Sales Channel
8.5.3 Transdermal Analgesics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る


 

Summary

The global market for Transdermal Analgesics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Transdermal Analgesics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transdermal Analgesics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Transdermal Analgesics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Transdermal Analgesics include Abbott Laboratories, AbbVie Inc., Bayer AG, Eli Lilly and Company, endo pharmaceuticals, Glaxosmithkline plc, johnson and johnson md&d, Pfizer, Inc., Reckitt Benckiser Group, Sanofi, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Analgesics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Transdermal Analgesics by region & country, by Type, and by Application.

The Transdermal Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Analgesics.

Market Segmentation
By Company
Abbott Laboratories
AbbVie Inc.
Bayer AG
Eli Lilly and Company
endo pharmaceuticals, Glaxosmithkline plc
johnson and johnson md&d
Pfizer, Inc.
Reckitt Benckiser Group
Sanofi
Segment by Type
Non opioids
Opioids
Segment by Application
Hospital
Pharmacy
Family
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transdermal Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Transdermal Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Transdermal Analgesics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.



ページTOPに戻る


Table of Contents

1 Market Overview
1.1 Transdermal Analgesics Product Introduction
1.2 Global Transdermal Analgesics Market Size Forecast
1.2.1 Global Transdermal Analgesics Sales Value (2020-2031)
1.2.2 Global Transdermal Analgesics Sales Volume (2020-2031)
1.2.3 Global Transdermal Analgesics Sales Price (2020-2031)
1.3 Transdermal Analgesics Market Trends & Drivers
1.3.1 Transdermal Analgesics Industry Trends
1.3.2 Transdermal Analgesics Market Drivers & Opportunity
1.3.3 Transdermal Analgesics Market Challenges
1.3.4 Transdermal Analgesics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transdermal Analgesics Players Revenue Ranking (2024)
2.2 Global Transdermal Analgesics Revenue by Company (2020-2025)
2.3 Global Transdermal Analgesics Players Sales Volume Ranking (2024)
2.4 Global Transdermal Analgesics Sales Volume by Company Players (2020-2025)
2.5 Global Transdermal Analgesics Average Price by Company (2020-2025)
2.6 Key Manufacturers Transdermal Analgesics Manufacturing Base and Headquarters
2.7 Key Manufacturers Transdermal Analgesics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Analgesics
2.9 Transdermal Analgesics Market Competitive Analysis
2.9.1 Transdermal Analgesics Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Analgesics Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Analgesics as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Non opioids
3.1.2 Opioids
3.2 Global Transdermal Analgesics Sales Value by Type
3.2.1 Global Transdermal Analgesics Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Transdermal Analgesics Sales Value, by Type (2020-2031)
3.2.3 Global Transdermal Analgesics Sales Value, by Type (%) (2020-2031)
3.3 Global Transdermal Analgesics Sales Volume by Type
3.3.1 Global Transdermal Analgesics Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Transdermal Analgesics Sales Volume, by Type (2020-2031)
3.3.3 Global Transdermal Analgesics Sales Volume, by Type (%) (2020-2031)
3.4 Global Transdermal Analgesics Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Family
4.2 Global Transdermal Analgesics Sales Value by Application
4.2.1 Global Transdermal Analgesics Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Transdermal Analgesics Sales Value, by Application (2020-2031)
4.2.3 Global Transdermal Analgesics Sales Value, by Application (%) (2020-2031)
4.3 Global Transdermal Analgesics Sales Volume by Application
4.3.1 Global Transdermal Analgesics Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Transdermal Analgesics Sales Volume, by Application (2020-2031)
4.3.3 Global Transdermal Analgesics Sales Volume, by Application (%) (2020-2031)
4.4 Global Transdermal Analgesics Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Transdermal Analgesics Sales Value by Region
5.1.1 Global Transdermal Analgesics Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Transdermal Analgesics Sales Value by Region (2020-2025)
5.1.3 Global Transdermal Analgesics Sales Value by Region (2026-2031)
5.1.4 Global Transdermal Analgesics Sales Value by Region (%), (2020-2031)
5.2 Global Transdermal Analgesics Sales Volume by Region
5.2.1 Global Transdermal Analgesics Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Transdermal Analgesics Sales Volume by Region (2020-2025)
5.2.3 Global Transdermal Analgesics Sales Volume by Region (2026-2031)
5.2.4 Global Transdermal Analgesics Sales Volume by Region (%), (2020-2031)
5.3 Global Transdermal Analgesics Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Transdermal Analgesics Sales Value, 2020-2031
5.4.2 North America Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Transdermal Analgesics Sales Value, 2020-2031
5.5.2 Europe Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Transdermal Analgesics Sales Value, 2020-2031
5.6.2 Asia Pacific Transdermal Analgesics Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Transdermal Analgesics Sales Value, 2020-2031
5.7.2 South America Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Transdermal Analgesics Sales Value, 2020-2031
5.8.2 Middle East & Africa Transdermal Analgesics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transdermal Analgesics Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Transdermal Analgesics Sales Value
6.2.1 Key Countries/Regions Transdermal Analgesics Sales Value, 2020-2031
6.2.2 Key Countries/Regions Transdermal Analgesics Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Transdermal Analgesics Sales Value, 2020-2031
6.3.2 United States Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Transdermal Analgesics Sales Value, 2020-2031
6.4.2 Europe Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Transdermal Analgesics Sales Value, 2020-2031
6.5.2 China Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.5.3 China Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Transdermal Analgesics Sales Value, 2020-2031
6.6.2 Japan Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Transdermal Analgesics Sales Value, 2020-2031
6.7.2 South Korea Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Transdermal Analgesics Sales Value, 2020-2031
6.8.2 Southeast Asia Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Transdermal Analgesics Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Transdermal Analgesics Sales Value, 2020-2031
6.9.2 India Transdermal Analgesics Sales Value by Type (%), 2024 VS 2031
6.9.3 India Transdermal Analgesics Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Information
7.1.2 Abbott Laboratories Introduction and Business Overview
7.1.3 Abbott Laboratories Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abbott Laboratories Transdermal Analgesics Product Offerings
7.1.5 Abbott Laboratories Recent Development
7.2 AbbVie Inc.
7.2.1 AbbVie Inc. Company Information
7.2.2 AbbVie Inc. Introduction and Business Overview
7.2.3 AbbVie Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 AbbVie Inc. Transdermal Analgesics Product Offerings
7.2.5 AbbVie Inc. Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Company Information
7.3.2 Bayer AG Introduction and Business Overview
7.3.3 Bayer AG Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bayer AG Transdermal Analgesics Product Offerings
7.3.5 Bayer AG Recent Development
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Information
7.4.2 Eli Lilly and Company Introduction and Business Overview
7.4.3 Eli Lilly and Company Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Eli Lilly and Company Transdermal Analgesics Product Offerings
7.4.5 Eli Lilly and Company Recent Development
7.5 endo pharmaceuticals, Glaxosmithkline plc
7.5.1 endo pharmaceuticals, Glaxosmithkline plc Company Information
7.5.2 endo pharmaceuticals, Glaxosmithkline plc Introduction and Business Overview
7.5.3 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Product Offerings
7.5.5 endo pharmaceuticals, Glaxosmithkline plc Recent Development
7.6 johnson and johnson md&d
7.6.1 johnson and johnson md&d Company Information
7.6.2 johnson and johnson md&d Introduction and Business Overview
7.6.3 johnson and johnson md&d Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 johnson and johnson md&d Transdermal Analgesics Product Offerings
7.6.5 johnson and johnson md&d Recent Development
7.7 Pfizer, Inc.
7.7.1 Pfizer, Inc. Company Information
7.7.2 Pfizer, Inc. Introduction and Business Overview
7.7.3 Pfizer, Inc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Pfizer, Inc. Transdermal Analgesics Product Offerings
7.7.5 Pfizer, Inc. Recent Development
7.8 Reckitt Benckiser Group
7.8.1 Reckitt Benckiser Group Company Information
7.8.2 Reckitt Benckiser Group Introduction and Business Overview
7.8.3 Reckitt Benckiser Group Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Reckitt Benckiser Group Transdermal Analgesics Product Offerings
7.8.5 Reckitt Benckiser Group Recent Development
7.9 Sanofi
7.9.1 Sanofi Company Information
7.9.2 Sanofi Introduction and Business Overview
7.9.3 Sanofi Transdermal Analgesics Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Sanofi Transdermal Analgesics Product Offerings
7.9.5 Sanofi Recent Development
8 Industry Chain Analysis
8.1 Transdermal Analgesics Industrial Chain
8.2 Transdermal Analgesics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transdermal Analgesics Sales Model
8.5.2 Sales Channel
8.5.3 Transdermal Analgesics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/01 10:27

150.82 円

163.67 円

197.69 円

ページTOPに戻る